Flare Therapeutics News and Activities

View the org chart displaying its 35 main executives

Most searched biographies at Flare Therapeutics

• Douglas Manion, Chief Executive Officer and Board Member
• Abbie Celniker, Chairman of the Board
• Kanishka Pothola, Board Member

Popular executive movements at Flare Therapeutics

• Michael Meyers, Chief Medical Officer, will retire on Jan. 31, 2026  (posted on January 12 2026).
• Stephen Eck has joined the company as Chief Medical Officer  (posted on January 12 2026).

Create your alert
to follow the executive moves at Flare Therapeutics.

Flare Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Flare Therapeutics

• Flare Therapeutics Reveals FX-909 Phase 1 Study Results
• Flare Therapeutics Presents Data at AACR 2024 Annual Meeting Characterizing PPARG-Derived Immune Cell Patterns in Urothelial Cancer Patients After Anti-PD1 Therapy - Flare Therapeutics
• News - Flare Therapeutics
• News & Publications - Flare Therapeutics

Social media about Flare Therapeutics

• Flare Therapeutics on Wikipedia, Google News & Yahoo Finance
• Flare Therapeutics on LinkedIn, X (Twitter) & YouTube